SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649494-16-000002
Filing Date
2016-05-03
Accepted
2016-05-03 13:07:57
Documents
1
Period of Report
2016-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146229526433116.html 4  
1 FORM 4 wf-form4_146229526433116.xml 4 4285
  Complete submission text file 0001649494-16-000002.txt   5896
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Adasczik Michael (Reporting) CIK: 0001649494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 161614628